RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 86 filers reported holding RAPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,090,796 | -14.6% | 125,800 | -3.9% | 0.00% | – |
| Q2 2023 | $2,447,830 | -30.8% | 130,900 | -32.1% | 0.00% | -100.0% |
| Q1 2023 | $3,535,421 | -0.8% | 192,666 | +7.0% | 0.00% | 0.0% |
| Q4 2022 | $3,565,584 | -19.3% | 180,080 | -1.9% | 0.00% | 0.0% |
| Q3 2022 | $4,419,000 | +284.3% | 183,645 | +191.5% | 0.00% | – |
| Q2 2022 | $1,150,000 | -42.4% | 63,000 | -30.6% | 0.00% | – |
| Q1 2022 | $1,997,000 | -58.0% | 90,808 | -29.9% | 0.00% | – |
| Q4 2021 | $4,756,000 | +194.5% | 129,518 | +149.1% | 0.00% | – |
| Q3 2021 | $1,615,000 | -83.2% | 52,000 | -82.8% | 0.00% | -100.0% |
| Q2 2021 | $9,597,000 | +104.5% | 301,893 | +42.8% | 0.00% | – |
| Q1 2021 | $4,693,000 | +46.0% | 211,404 | +29.9% | 0.00% | – |
| Q4 2020 | $3,214,000 | – | 162,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |